Prostatilen

Overview

Prostatilen is a polypeptide bioregulator extracted from bovine prostate tissue, with a usage history concentrated in Eastern Europe since the 1990s. It is said to act selectively on prostate tissue, bringing anti-inflammatory, immune-modulating, and microcirculation-boosting effects. Reported uses include chronic prostatitis, benign prostatic hyperplasia (BPH), male infertility from impaired sperm production, and urinary dysfunction. Like other peptides, it is typically handled as a research-grade product requiring reconstitution and injection, where purity and storage are real concerns.

Editorial verdict

Prostatilen has a surprisingly substantial clinical literature for a tissue-extract bioregulator, and the human data lean strongly positive. The honest caveats are that nearly all of it comes from Russia and Ukraine, much of it is older, and the animal mutagenicity finding deserves to be taken seriously rather than buried. Promising, but read the fine print.

Evidence quality

We grade the research A+, weighted across 36 peer-reviewed studies: 11 RCTs, 6 observational, 15 animal, 2 in vitro, and 2 reviews. Of the 36 classified findings, 33 supported the compound, 2 were mixed, and 1 refuted it. The human base of 11 RCTs is solid by peptide standards.

What the research shows

An observational study of a zinc-enhanced version (Prostatilen AC) reported improved spermatogenesis in men aged 25-45 with chronic abacterial prostatitis and reproductive dysfunction. In rat models of chronic prostatitis, Prostatilen AC produced marked anti-inflammatory effects, lowered prostate weight and inflammatory markers, normalized urination, raised diuresis and testosterone, and showed antioxidant activity. A clinical study in 52 patients with chronic prostatitis and prostatic adenoma found reduced pain and urinary symptoms, better sexual function and spermatogenesis, higher uroflowmetric indices, and antibacterial and immunomodulatory effects without adverse reactions. A large series of 1,115 patients with chronic pyelonephritis and prostatitis reported corrected hemocoagulation and immunity problems, restored microcirculation, and suppressed inflammation. Additional work showed normalization of hemostatic parameters, prevention of drug-induced prostatic hyperplasia in rats over 30 days, and a 96.7% symptom-relief rate among 307 chronic prostatitis patients dosed at 5-10 mg IM for 5-10 days. Animal studies also suggested stimulation of spermatogenesis and androgenic testicular function, supporting a possible role in male infertility.

Who should be cautious

The key safety flag is animal mutagenicity: one study reported chromosomal aberrations in mice at 5-microgram doses, though 2.5-microgram doses did not, and immobilizing the peptide in polyvinyl alcohol reduced that potential. Beyond that, the evidence base is geographically narrow, so generalizing to other populations carries uncertainty.

Dosage

The core regimen is 5-10 mg intramuscularly once daily for 5-10 days. A 30 mg rectal suppository containing dimexide has also been studied for BPH symptoms. Courses generally run 5-10 days, with effects emerging after 2-3 days and peaking around day 5-6. The Prostatilen AC suppository adds zinc arginyle-glycinate dihydrochloride for reproductive benefit.

Effectiveness

Clinical effects usually appear after 2-3 injections and peak after 5-6. Studies report up to 96.7% of chronic prostatitis patients seeing symptoms vanish or ease. Benefits extend beyond the prostate to chronic pyelonephritis, with antibacterial activity noted, and the zinc-enhanced AC formula appears to help spermatogenesis and reproductive parameters in particular.

Availability

Prostatilen is mainly available and studied in Eastern Europe, especially Russia and Ukraine, with little Western footprint. The literature treats it as a registered pharmaceutical requiring medical supervision, given by injection or suppository. Forms include injectable solutions (5-10 mg), 30 mg rectal suppositories, and the zinc-containing Prostatilen AC.

Community sentiment

User feedback is scarce, drawn from just 2 community reports, with improved urinary function the only highlighted effect.